Latest filing published 11 Sept 2026 for Carlyle Group Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David M. Rubenstein, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Carlyle Group Inc. and Moderna, Inc. In total, 19 filings cover trades dated from 1 January 2020 to 11 September 2026.
Every open-market trade on record is a sale: 13 sales worth €666.8M. Outside the open market, there are 2 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
The record was last updated on 11 September 2026 with a transaction in Carlyle Group Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations